Clinical and Biological Significances of FBLN5 in Gastric Cancer
Abnormal FBLN5 expression levels are related to various cancer types. This study is the first to explore its clinical and biological significances in gastric cancer (GC). We used The Cancer Genome Atlas-GC (TCGA-GC) and Gene Expression Omnibus (GEO) databases to identify the differential expression...
Main Authors: | Xiulan Bian, Shengjie Yin, Xin Yin, Tianyi Fang, Yufei Wang, Shuo Yang, Xinju Jiang, Yingwei Xue, Fei Ye, Lei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/2/553 |
Similar Items
-
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
by: Tianyi Fang, et al.
Published: (2023-01-01) -
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer
by: Shuo Yang, et al.
Published: (2023-09-01) -
New insight into clinical heterogeneity and inheritance diversity of FBLN5-related cutis laxa
by: Jalal Gharesouran, et al.
Published: (2021-01-01) -
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer
by: Yi Hao, et al.
Published: (2021-02-01) -
Synergistic effects of rare variants of ARHGAP31 and FBLN1 in vitro in terminal transverse limb defects
by: Hong Tian, et al.
Published: (2022-09-01)